Is Pediatrix Medical Group, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Pediatrix Medical Group, Inc. moved from attractive to very attractive, indicating a positive shift in its valuation outlook. The company appears undervalued, supported by a P/E ratio of 8, a PEG ratio of 0.19, and an EV to EBITDA ratio of 7.17. In comparison to peers, Hims & Hers Health, Inc. has a significantly higher P/E ratio of 54.76, while Addus HomeCare Corp. shows a fair valuation with a P/E of 22.05.
Pediatrix Medical Group has demonstrated strong returns, with a year-to-date return of 25.38% compared to the S&P 500's 13.30%, reinforcing its attractive valuation story. Additionally, the company's ROE stands at 19.10%, further highlighting its efficient use of equity.